Compare $SCTX vs $USBC | Chartloom

Compare

$SCTX vs $USBC

Scribe Therapeutics Inc · USBC Inc

SCTX

Scribe Therapeutics Inc

USBC

USBC Inc

Compare $SCTX vs $USBC

Comparing Scribe Therapeutics Inc and USBC Inc

SCTXScribe Therapeutics Inc

USBCUSBC Inc

SCTXScribe Therapeutics Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.61x

Rev growth (TTM)

—

YTD performance

-2.2%

52W performance

-2.2%

FCF yield

0.0%

USBCUSBC Inc

Market cap

$198M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-51.9%

FCF yield

-11.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SCTX

USBC

Detailed metrics comparison

SCTX

Scribe Therapeutics Inc

USBC

USBC Inc

Market Cap

SCTX$372M

USBC$198M

Enterprise Value

SCTX$374M

USBC$210M

Price

SCTX$21.17

USBC$0.51

P/E Ratio

SCTXN/A

USBCN/A

P/S Ratio

SCTX0.00x

USBC0.00x

EV/Sales

SCTX0.00x

USBC0.00x

EV/EBITDA

SCTX0.00x

USBC0.00x

P/B Ratio

SCTXN/A

USBC4.46x

P/FCF Ratio

SCTXN/A

USBCN/A

EV/FCF

SCTX0.00x

USBC-9.14x

PEG Ratio

SCTXN/A

USBCN/A

Forward P/E (NTM)

SCTXN/A

USBCN/A

Forward P/S (NTM)

SCTX29.61x

USBCN/A

Revenue (TTM)

SCTX$0

USBC$0

Revenue Growth (YoY)

SCTXN/A

USBCN/A

Forward Rev Growth

SCTX-43.3%

USBC0.0%

Gross Margin (TTM)

SCTX0.0%

USBC0.0%

Operating Margin (TTM)

SCTX0.0%

USBC0.0%

EBITDA Margin (TTM)

SCTX0.0%

USBC0.0%

Net Margin (TTM)

SCTX0.0%

USBC0.0%

FCF Margin (TTM)

SCTXN/A

USBCN/A

Net Income (TTM)

SCTXN/A

USBC$-86M

FCF (TTM)

SCTX$0

USBC$-23M

EPS (TTM)

SCTX$0.00

USBC-$0.22

ROE (TTM)

SCTX0.0%

USBC-12093.0%

ROA (TTM)

SCTX0.0%

USBC-9639.0%

ROIC (TTM)

SCTX0.0%

USBC-11297.0%

Cash

SCTX$36M

USBC$3M

Debt

SCTX$38M

USBC$15M

Net Cash/Debt

SCTX$-2M

USBC$-12M

Current Ratio (TTM)

SCTX0.57x

USBC0.23x

Quick Ratio (TTM)

SCTX0.56x

USBC0.20x

Debt/Equity (TTM)

SCTX0.00x

USBC0.32x

Debt/Assets (TTM)

SCTX0.0%

USBC0.0%

Interest Coverage (TTM)

SCTXN/A

USBCN/A

Net Debt/EBITDA (TTM)

SCTX0.00x

USBC0.00x

Beta

SCTX-2.64

USBC2.77

52W Performance

SCTX-2.2%

USBC-51.9%

YTD Performance

SCTX-2.2%

USBC-22.2%

% from 52W High

SCTX-46.5%

USBC-60.5%

% from 52W Low

SCTX56.8%

USBC78.7%

Asset Turnover (TTM)

SCTX0.00x

USBC0.00x

FCF Yield (TTM)

SCTX0.0%

USBC-11.6%

Earnings Yield (TTM)

SCTX0.0%

USBC-43.5%

Dividend Yield (TTM)

SCTXN/A

USBCN/A

Rule of 40

SCTX0.0

USBC0.0

EV/GP/RG

SCTXN/A

USBCN/A

Ticker research

View SCTX research View USBC research

Metric	SCTX Scribe Therapeutics Inc	USBC USBC Inc
Market & Valuation
Market Cap	$372M	$198M
Enterprise Value	$374M	$210M
Price	$21.17	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.61x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-43.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	N/A	$-86M
FCF (TTM)	$0	$-23M
EPS (TTM)	$0.00	-$0.22
ROE (TTM)	0.0%	-12093.0%
ROA (TTM)	0.0%	-9639.0%
ROIC (TTM)	0.0%	-11297.0%
Financial Health
Cash	$36M	$3M
Debt	$38M	$15M
Net Cash/Debt	$-2M	$-12M
Current Ratio (TTM)	0.57x	0.23x
Quick Ratio (TTM)	0.56x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.64	2.77
52W Performance	-2.2%	-51.9%
YTD Performance	-2.2%	-22.2%
% from 52W High	-46.5%	-60.5%
% from 52W Low	56.8%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-11.6%
Earnings Yield (TTM)	0.0%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View SCTX research	View USBC research

Valuation

P/S Ratio

SCTX

0.00x

USBC

0.00x

EV/FCF

USBC

-9.14x

SCTX

0.00x

Growth & revenue

Forward Revenue Growth

USBC

0.0%

SCTX

-43.3%

Profitability & performance

Gross Margin

SCTX

0.0%

USBC

0.0%

ROE

SCTX

0.0%

USBC

-12093.0%

FCF Yield %

SCTX

0.0%

USBC

-11.6%

52-Week Performance

SCTX

-2.2%

USBC

-51.9%

Detailed metrics comparison

SCTX

Scribe Therapeutics Inc

USBC

USBC Inc

Market Cap

SCTX$372M

USBC$198M

Enterprise Value

SCTX$374M

USBC$210M

Price

SCTX$21.17

USBC$0.51

P/E Ratio

SCTXN/A

USBCN/A

P/S Ratio

SCTX0.00x

USBC0.00x

EV/Sales

SCTX0.00x

USBC0.00x

EV/EBITDA

SCTX0.00x

USBC0.00x

P/B Ratio

SCTXN/A

USBC4.46x

P/FCF Ratio

SCTXN/A

USBCN/A

EV/FCF

SCTX0.00x

USBC-9.14x

PEG Ratio

SCTXN/A

USBCN/A

Forward P/E (NTM)

SCTXN/A

USBCN/A

Forward P/S (NTM)

SCTX29.61x

USBCN/A

Revenue (TTM)

SCTX$0

USBC$0

Revenue Growth (YoY)

SCTXN/A

USBCN/A

Forward Rev Growth

SCTX-43.3%

USBC0.0%

Gross Margin (TTM)

SCTX0.0%

USBC0.0%

Operating Margin (TTM)

SCTX0.0%

USBC0.0%

EBITDA Margin (TTM)

SCTX0.0%

USBC0.0%

Net Margin (TTM)

SCTX0.0%

USBC0.0%

FCF Margin (TTM)

SCTXN/A

USBCN/A

Net Income (TTM)

SCTXN/A

USBC$-86M

FCF (TTM)

SCTX$0

USBC$-23M

EPS (TTM)

SCTX$0.00

USBC-$0.22

ROE (TTM)

SCTX0.0%

USBC-12093.0%

ROA (TTM)

SCTX0.0%

USBC-9639.0%

ROIC (TTM)

SCTX0.0%

USBC-11297.0%

Cash

SCTX$36M

USBC$3M

Debt

SCTX$38M

USBC$15M

Net Cash/Debt

SCTX$-2M

USBC$-12M

Current Ratio (TTM)

SCTX0.57x

USBC0.23x

Quick Ratio (TTM)

SCTX0.56x

USBC0.20x

Debt/Equity (TTM)

SCTX0.00x

USBC0.32x

Debt/Assets (TTM)

SCTX0.0%

USBC0.0%

Interest Coverage (TTM)

SCTXN/A

USBCN/A

Net Debt/EBITDA (TTM)

SCTX0.00x

USBC0.00x

Beta

SCTX-2.64

USBC2.77

52W Performance

SCTX-2.2%

USBC-51.9%

YTD Performance

SCTX-2.2%

USBC-22.2%

% from 52W High

SCTX-46.5%

USBC-60.5%

% from 52W Low

SCTX56.8%

USBC78.7%

Asset Turnover (TTM)

SCTX0.00x

USBC0.00x

FCF Yield (TTM)

SCTX0.0%

USBC-11.6%

Earnings Yield (TTM)

SCTX0.0%

USBC-43.5%

Dividend Yield (TTM)

SCTXN/A

USBCN/A

Rule of 40

SCTX0.0

USBC0.0

EV/GP/RG

SCTXN/A

USBCN/A

Ticker research

View SCTX research View USBC research

Metric	SCTX Scribe Therapeutics Inc	USBC USBC Inc
Market & Valuation
Market Cap	$372M	$198M
Enterprise Value	$374M	$210M
Price	$21.17	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.61x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-43.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	N/A	$-86M
FCF (TTM)	$0	$-23M
EPS (TTM)	$0.00	-$0.22
ROE (TTM)	0.0%	-12093.0%
ROA (TTM)	0.0%	-9639.0%
ROIC (TTM)	0.0%	-11297.0%
Financial Health
Cash	$36M	$3M
Debt	$38M	$15M
Net Cash/Debt	$-2M	$-12M
Current Ratio (TTM)	0.57x	0.23x
Quick Ratio (TTM)	0.56x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.64	2.77
52W Performance	-2.2%	-51.9%
YTD Performance	-2.2%	-22.2%
% from 52W High	-46.5%	-60.5%
% from 52W Low	56.8%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-11.6%
Earnings Yield (TTM)	0.0%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View SCTX research	View USBC research